Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Y-site co-infusion of dexamethasone vs standard dexamethasone premedication for prevention of oxaliplatin-related hypersensitivity and venous pain
TCTR20250120003Phase 2Completed
- Sponsor
- Phramongkutklao Hospital and College of Medicine
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in cancer, sponsored by Phramongkutklao Hospital and College of Medicine. Started Mar 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
cancer
Beyond the preview
Go deeper on TCTR20250120003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250120003.